2m 2m 2m 2m 2m 2m 2m
Smith&Nephew Sp ADR (SNN)
NYSE
$29.61+$0.21 (+0.73%)
Price as of Jun 23, 2026 4:10 PM EDT- $12.5BMarket Cap
- 3.13%1-Year Change
- Medical DevicesIndustry
Smith&Nephew Sp ADR (SNN)
$29.61+$0.21 (+0.73%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.2B +6.09% | 5.8B +4.70% | 5.5B +6.40% | 5.2B +0.06% | |
Cost of Revenue | 2.0B +11.79% | 1.8B +1.97% | 1.7B +12.34% | 1.5B -0.19% | |
Gross Profit | 4.2B +3.61% | 4.0B +5.94% | 3.8B +3.92% | 3.7B +0.16% | |
Sales and Marketing Expense | 91.0M +8.33% | 84.0M -4.55% | 88.0M -96.94% | 2.9B +5.88% | |
Research and Development Expense | -296.0M +2.42% | -289.0M -14.75% | -339.0M -1.74% | -345.0M -3.09% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 3.1B +0.06% | 3.1B +1.47% | 3.1B +6.08% | 2.9B +5.88% | |
Operating Profit | 794.0M +20.85% | 657.0M +54.59% | 425.0M -5.56% | 450.0M -24.11% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -140.0M -3.45% | -145.0M +9.85% | -132.0M +65.00% | -80.0M 0.00% | |
Interest Income and Expense and Net | -140.0M -3.45% | -145.0M +9.85% | -132.0M +65.00% | -80.0M 0.00% | |
Total Nonoperating Income and Expense | 140.0M -3.45% | 145.0M +9.85% | 132.0M +65.00% | 80.0M 0.00% | |
Income before Taxes | 625.0M +51.70% | 412.0M +56.65% | 263.0M +17.94% | 223.0M -57.44% | |
Income Taxes | 154.0M +79.07% | 86.0M +218.52% | 27.0M +125.00% | 12.0M -80.65% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 625.0M +51.70% | 412.0M +56.65% | 263.0M +17.94% | 223.0M -57.44% | |
Net Income from Continuing Operations Applicable to Common | 625.0M +51.70% | 412.0M +56.65% | 263.0M +17.94% | 223.0M -57.44% | |
Basic EPS and Net Income | 0.72 +52.75% | 0.47 +56.29% | 0.30 +18.43% | 0.26 -99.57% | |
Diluted EPS and Net Income | 0.72 +52.34% | 0.47 +56.15% | 0.30 +18.04% | 0.26 -99.57% | |
Basic Weighted Average Shares | 867.0M -0.69% | 873.0M +0.23% | 871.0M -0.11% | 872.0M -0.57% | |
Diluted Weighted Average Shares | 867.0M -0.69% | 873.0M +0.23% | 871.0M -0.11% | 872.0M -0.57% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 557.0M -10.02% | 619.0M +106.33% | 300.0M -12.79% | 344.0M -73.23% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 557.0M -10.02% | 619.0M +106.33% | 300.0M -12.79% | 344.0M -73.23% | |
Total Current Assets | 4.1B -7.19% | 4.4B +9.70% | 4.0B +4.51% | 3.9B -12.84% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 1.5B -3.83% | |
Total Long-Term Assets | 6.4B +7.10% | 5.9B -0.40% | 6.0B -2.50% | 6.1B -5.94% | |
Total Assets | 10.5B +0.99% | 10.4B +3.67% | 10.0B +0.21% | 10.0B -8.74% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 83.0M +4,050.00% | 2.0M -99.72% | 710.0M +539.64% | 111.0M -74.48% | |
Total Current Liabilities | 1.6B +4.18% | 1.5B -32.58% | 2.3B +32.42% | 1.7B -19.52% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 3.6B +0.42% | 3.6B +42.38% | 2.5B -16.48% | 3.0B -7.11% | |
Total Liabilities | 5.2B +1.55% | 5.1B +6.69% | 4.8B +1.34% | 4.7B -12.05% | |
Retained Earnings | 5.3B +6.08% | 5.0B +2.28% | 4.9B -2.39% | 5.0B -3.81% | |
Total Stockholders Equity | 175.0M -96.68% | 5.3B +0.92% | 5.2B -0.80% | 5.3B -5.55% | |
Total Shares Outstanding | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | 1.3B +30.19% | 987.0M +62.34% | 608.0M +29.91% | 468.0M -46.64% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -406.0M -28.65% | -569.0M +27.01% | -448.0M -5.08% | -472.0M -31.69% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -955.0M +1,010.47% | -86.0M -57.00% | -200.0M -78.40% | -926.0M +43.57% | |
Financials Ratio | |||||
Gross Margin | 68.01% -2.34% | 69.64% +1.18% | 68.82% -2.34% | 70.47% +0.11% | |
Operating Margin | 12.88% +13.91% | 11.31% +47.64% | 7.66% -11.24% | 8.63% -24.16% | |
Return on Assets | 6.01% +48.27% | 4.05% +53.66% | 2.64% +23.45% | 2.14% -55.31% | |
Return on Equity | 22.98% +192.30% | 7.86% +56.56% | 5.02% +21.89% | 4.12% -57.36% | |
Revenue Growth | 6.09% +29.54% | 4.70% -26.56% | 6.40% +11,019.10% | 0.06% -99.60% | |
Current Ratio | 2.57 -10.92% | 2.89 +62.73% | 1.77 -21.08% | 2.25 +8.30% | |
Cash Ratio | 0.35 -13.63% | 0.40 +206.06% | 0.13 -34.15% | 0.20 -66.73% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow